Price Snapshot
Qsymia prices in the United States vary by strength, pharmacy, geography, and whether you are filling brand or generic. What follows is a mid-2026 snapshot based on publicly-posted pharmacy pricing and discount-card data. Prices move — always verify at the point of purchase.
| Scenario | Typical Range / Month | Notes |
|---|---|---|
| Brand Qsymia — cash | $220 – $275 | All 4 strengths similar pricing |
| Brand Qsymia — Engage savings card | $98 | Commercial insurance required; no Medicare/Medicaid |
| Generic phentermine/topiramate ER — cash | $55 – $85 | Launched 2022; discount cards essential |
| Generic — insurance copay | $15 – $45 | If plan covers it (many exclude) |
| Qsymia — Medicare Part D | Not typically covered | Federal rules exclude most weight-loss drugs |
Pricing sources: publicly available discount-card quotes (GoodRx, SingleCare), retail-pharmacy inquiries, and the manufacturer savings program terms. As of April 2026; subject to change.
Brand Qsymia Price
Brand Qsymia's wholesale acquisition cost (WAC) — the list price before any rebates — has sat in the $250–$260 range for several years. Retail pharmacies apply a markup that brings the typical cash price to $220–$275 at chain pharmacies and mail-order, with some independent pharmacies going as high as $300.
The price does not scale by dose. 3.75/23 and 15/92 are priced identically at most pharmacies — you pay for the formulation, not the milligrams. That matters when you're cost-forecasting: there's no cheaper starter phase. From day one, you're paying brand-Qsymia money for a 3.75/23 starter capsule.
Generic Phentermine / Topiramate ER
Phentermine/topiramate ER (generic Qsymia) became available in the US in 2022 after the drug's original patents expired. Several manufacturers now produce authorized generics, priced at about 25–35% of the brand. Cash pricing for the generic typically runs:
- 3.75/23 and 7.5/46 — $55–$70 / month
- 11.25/69 and 15/92 — $65–$85 / month
Using GoodRx or SingleCare discount cards can bring the generic under $50/month at certain pharmacies in certain ZIP codes. The generic is dispensed under the same REMS program as brand Qsymia — you don't avoid the paperwork by going generic, only the price premium.
Therapeutic equivalence: the FDA considers AB-rated generic phentermine/topiramate ER clinically interchangeable with brand Qsymia. The active ingredient, strengths, and extended-release formulation match. Some patients report subjective differences in how a given generic "feels" (common with topiramate products across indications), which may justify sticking with brand for patients well-established on it — but most prescribers will default-prescribe the generic now.
How Much Is Qsymia Without Insurance?
If you're paying cash with no insurance coverage, expect:
| Pharmacy type | Brand | Generic |
|---|---|---|
| Chain pharmacy (CVS, Walgreens, Rite Aid) | $240–$275 | $65–$85 |
| Walmart / Target (CVS) | $225–$250 | $55–$75 |
| Costco Pharmacy | $220–$245 | $55–$75 |
| Certified mail-order | $220–$260 | $60–$80 |
| Amazon Pharmacy | $230–$250 | $55–$75 |
| Independent pharmacy | Wide variation | Wide variation |
Pro tip: because Qsymia is dispensed under REMS, not every pharmacy can fill it — only REMS-certified pharmacies. Your prescriber will usually direct the prescription to a specific mail-order pharmacy that specializes in the REMS workflow. Shopping pharmacies on price is possible but limited by certification.
Manufacturer Savings Card (Qsymia Engage)
Currax Pharmaceuticals, the current marketer of brand Qsymia, operates a savings program called Qsymia Engage. Eligible patients can pay as little as $98 for a month's supply of brand Qsymia, regardless of the tier their insurance places it in. The program covers the cost difference between the patient's actual copay and the $98 target, up to an annual per-patient cap.
Eligibility requirements:
- Must have commercial / private insurance (employer-sponsored, marketplace, or direct-purchase)
- Must have an active Qsymia prescription from a licensed US prescriber
- Not eligible: Medicare (Part D, Advantage), Medicaid, TRICARE, VA, or any federally-funded health benefit
- Must enroll through the Qsymia Engage website
The $98 price applies to brand Qsymia. The savings card does not apply to generic phentermine/topiramate ER.
Qsymia Coupons
Patients not eligible for Qsymia Engage — or who want a straight discount without insurance — typically use third-party discount cards:
- GoodRx — strongest on generic phentermine/topiramate ER; prices under $60/month at participating pharmacies.
- SingleCare — similar to GoodRx, sometimes better on brand Qsymia (down to ~$195 in some markets).
- RxSaver — covers both brand and generic; variable pricing by ZIP code.
- WellRx — strongest on independent pharmacies; worth checking for REMS-certified independents in your area.
Caveat: discount cards can't be stacked with insurance, and they don't work for controlled-substance prescriptions in every state. Present the card at checkout; if the pharmacist can't process it, they'll tell you before you pay.
Costco & Pharmacy Comparison
Costco consistently comes in at the lower end for both brand and generic Qsymia, partly because Costco Pharmacy operates on a lower markup model than traditional chains. You do not need a Costco membership to use the pharmacy — it's one of the few Costco services open to non-members. Walmart's "$4 list" does not include Qsymia.
Comparison shopping before you fill is worth the 15 minutes. Call three REMS-certified pharmacies in your area and ask for the cash price on your exact dose — there can be $40–$60/month variation inside a single ZIP code.
Does Insurance Cover Qsymia?
The honest answer: often, no. Weight-loss medications — including Qsymia, Wegovy, Zepbound, Saxenda, and orlistat — are excluded from the majority of US commercial insurance plans and from nearly all Medicare Part D plans.
When a commercial plan does cover Qsymia, coverage usually requires:
- Prior authorization from the prescriber documenting BMI ≥ 30 (or ≥ 27 with comorbidity)
- Evidence of prior lifestyle intervention — typically 6 months of documented diet and exercise
- Renewal authorization at 12 weeks confirming ≥3% weight loss
- Ongoing renewal annually based on sustained response
Medicare Part D historically does not cover Qsymia for weight loss indications. Congressional proposals to expand Medicare obesity-drug coverage have been introduced multiple times but as of April 2026 have not become law. Medicaid coverage varies by state — a minority of states cover Qsymia under the weight-management benefit, typically with prior authorization and BMI thresholds above 30.
Qsymia on Amazon — What to Know
Amazon Pharmacy, Amazon's prescription drug division, does fill Qsymia prescriptions in most states where it operates. As a controlled substance (Schedule IV) that also falls under a REMS, Qsymia requires a valid prescription transferred through the REMS workflow — which means Amazon Pharmacy has to be certified, and the prescriber has to direct the prescription there. You cannot order Qsymia over-the-counter from Amazon or any other online retailer. Listings that appear to show "Qsymia pills" on Amazon's general marketplace (without a prescription workflow) are not legitimate and should not be trusted.
Amazon Pharmacy pricing for brand Qsymia is generally in the $230–$250/month range, with Prime members sometimes seeing an additional small discount. Generic pricing is similar to other major chains.
Cost-Per-Pound-Lost vs GLP-1
Month-to-month, generic Qsymia is cheaper than any GLP-1. But most patients don't buy weight-loss drugs by the month — they buy them by the pound. Here's the math, using trial-mean efficacy and mid-range 2026 pricing:
| Medication | Monthly cost (mid) | 56-week cost | Mean weight loss | Pounds lost (200-lb pt) | $ / lb lost |
|---|---|---|---|---|---|
| Generic phen/top ER 15/92 | $70 | $910 | ~10% | 20 lb | ~$46 |
| Brand Qsymia 15/92 | $250 | $3,250 | ~10% | 20 lb | ~$163 |
| Compounded semaglutide (telehealth) | $199 | $2,587 | ~15% | 30 lb | ~$86 |
| Compounded tirzepatide (telehealth) | $299 | $3,887 | ~21% | 42 lb | ~$93 |
| Wegovy (brand, cash) | $1,349 | $17,537 | ~15% | 30 lb | ~$585 |
Reading the table: Generic Qsymia has the lowest cost-per-pound-lost if you respond at the trial mean. Brand Qsymia is roughly double the cost-per-pound of compounded telehealth GLP-1s because brand pricing dominates. Brand Wegovy at retail is the most expensive per pound by a wide margin.
That said, cost-per-pound-lost is not the whole story. It doesn't price in the REMS administrative cost, side-effect management, or the probability of reaching the trial mean — which is higher for GLP-1s than for Qsymia in recent real-world data. For patients who care about total pounds lost (not just pounds per dollar), GLP-1s often remain preferable even when Qsymia looks cheaper on the month.
The Hidden Costs of Qsymia
The sticker price is not the full cost of Qsymia. Items that often show up on the patient's actual out-of-pocket bill but don't make it into most price comparisons:
- Monthly pregnancy tests (required by REMS for patients of reproductive potential) — $15–$40/month for home tests or clinic visits
- Kidney function / bicarbonate bloodwork — typically at baseline, 3 months, 6 months, annually; $50–$150 per draw if uninsured
- Ophthalmology screening if glaucoma symptoms arise — $150–$400 per visit
- Kidney-stone workup if stones develop — can run $1,500+ for imaging, labs, urology consultation
- Dental visits — increased frequency often recommended due to chronic dry mouth
- Mood/psychiatric follow-up for patients with baseline mental-health history — typically $150–$300/visit
None of these are hypothetical — each corresponds to a real clinical monitoring expectation in the Qsymia label. Most patients on GLP-1s don't incur the equivalent of these line items because the side-effect profile is different and there is no REMS.
A Modern Approach Exists
Qsymia was FDA-approved in 2012 — a repurposed stimulant plus an anti-seizure drug. Since then, an entirely new drug class has redefined obesity medicine: GLP-1 receptor agonists. For most patients today, they are more effective and easier to manage.
- 2–3× more weight loss in trials (15–22% vs 7–10% with Qsymia)
- Not a controlled substance — no DEA schedule, no REMS enrollment
- Hormone-based (GLP-1 agonist) — no stimulant, no amphetamine lineage
- Daily oral tablet or once-weekly injection, delivered to your door
- Transparent pricing from $179/month with licensed US providers
- Cancel anytime — no long-term commitment
Licensed US clinicians · HIPAA protected · Medication shipped from US pharmacies
Frequently Asked Questions
How much does Qsymia cost per month?
Cash price for brand Qsymia in 2026 typically runs $220–$275 per month at major US retail pharmacies. With the manufacturer savings card, eligible commercially-insured patients may pay as little as $98 per month for brand Qsymia. The generic phentermine/topiramate ER runs $55–$85 per month cash.
How much is Qsymia without insurance?
Without insurance, expect a cash price of $220–$275/month for brand Qsymia at major pharmacies. Walmart, Costco, and online discount pharmacies often come in at the lower end. The generic phentermine/topiramate ER (launched 2022) is substantially cheaper — $55–$85/month cash using a discount card. Actual pricing varies by ZIP code and by dose (15/92 mg is typically a few dollars more than 7.5/46 mg).
Is there a generic version of Qsymia?
Yes. A generic phentermine/topiramate ER became available in the United States in 2022 after patent expiration. It contains the same two active ingredients in the same four strengths (3.75/23, 7.5/46, 11.25/69, 15/92). Cash pricing is about 25–35% of brand Qsymia. The generic is dispensed under REMS just like the brand.
What is the Qsymia manufacturer coupon?
Currax Pharmaceuticals offers a Qsymia Engage savings program: eligible patients with commercial insurance can pay as little as $98 per month for brand Qsymia, with an annual cap on manufacturer contribution. The program is not available to patients covered by government insurance (Medicare, Medicaid, VA, TRICARE). Enrollment is through qsymia.com.
Does insurance cover Qsymia?
Coverage is inconsistent. Most commercial insurance plans exclude weight-loss drugs from their formularies as a category, which covers Qsymia, the GLP-1s approved for weight loss, and orlistat. When a plan does cover Qsymia, it typically requires prior authorization demonstrating BMI ≥ 30 (or ≥ 27 with comorbidity) plus documented prior lifestyle intervention. Medicare Part D does not cover weight-loss drugs except in very narrow circumstances (type 2 diabetes indications).
How much is Qsymia at Costco?
Costco pharmacy cash pricing for brand Qsymia tends to run $220–$245 per month as of early 2026 — toward the lower end of the retail range. Costco members and non-members can use the pharmacy. Generic phentermine/topiramate ER at Costco typically runs $55–$75/month. Prices vary by location and change frequently; verify at the counter or via Costco Pharmacy online.
Can I buy Qsymia on Amazon?
Amazon Pharmacy does fill controlled-substance prescriptions including Qsymia in most US states, but Qsymia is only available with a valid prescription — it is not sold over-the-counter, and any listing claiming otherwise is not legitimate. Before ordering, confirm the prescription has been transferred through the REMS-certified prescriber and pharmacy workflow. Pricing on Amazon Pharmacy is comparable to mid-range retail.
Is Qsymia cheaper than GLP-1 medications?
On a per-month basis, yes. Generic phentermine/topiramate ER at $55–$85/month is substantially cheaper than any FDA-approved GLP-1 for weight loss. However, on a cost-per-pound-lost basis the comparison is closer: GLP-1s typically produce 2× more weight loss over the same period. Telehealth GLP-1 programs start at $179/month for compounded semaglutide or tirzepatide, narrowing the practical gap further.
- FDA. Qsymia Prescribing Information.
- Currax Pharmaceuticals. Qsymia Engage Savings Program — Terms & Conditions.
- GoodRx / SingleCare / RxSaver. Public discount-card pricing data for phentermine/topiramate ER and brand Qsymia, April 2026.
- Centers for Medicare & Medicaid Services. Part D Formulary guidance on weight-loss drugs.
- STEP 1 and SURMOUNT-1 trial data (for GLP-1 efficacy used in cost-per-pound calculations).